Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, signaling a new version of the ClinicalTrials.gov page. This change represents a backend update rather than a modification to the study details or eligibility criteria.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision was updated from v3.6.3 to v3.6.4, indicating a maintenance update to the page's record.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision stamp was updated from v3.6.2 to v3.6.3. This indicates a minor backend update rather than changes to study details or user-facing content.SummaryDifference0.1%

- Check58 days agoChange DetectedUpdated the page revision from v3.6.0 to v3.6.2, indicating a minor metadata update to the study details page. This change does not alter the study data or user-facing content.SummaryDifference0.1%

- Check72 days agoChange DetectedThe study page now includes sponsor and collaborating institution details (Alona Zer and Rabin Medical Center) and updates metadata with Last Verified and a new Revision: v3.6.0. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label formatting was standardized.SummaryDifference2%

- Check79 days agoChange DetectedThe bottom revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.